NIH Award Supporting the Somatic Cell Genome Editing Consortium

Image by R. Holland Cheng
UC Davis researchers have used a hepatitis E capsid to deliver CRISPR-Cas9 editing to gut cells in mice. The technique could allow patients to take a genome editing therapy by mouth. (Image by R. Holland Cheng).

The NIH has allocated US$190 million over 6 years in support of the Somatic Cell Genome Editing (SCGE) Consortium, which now includes 72 principal investigators from 38 institutions that are pursuing 45 distinct but well-integrated projects. The Genome Center professor David Segal is part of three projects at UC Davis, along with Alice Tarantal, Dennis Hartigan-O'Connor, Kit Lam, and R. Holland Cheng. A paper describing this effort appears in the April 8, 2021 issue of Nature

Read the press release here on Egghead.